Back to Research Hub
Omeros Corporation
OMER
$19.40+0.08 (+0.40%)
Omeros Corporation is a biopharmaceutical firm with commercialized products, actively engaged in the discovery, development, and market introduction of both small-molecule and protein-based therapies, including treatments for rare diseases.
StreetsValue research for Omeros Corporation (OMER)
Members get the full report for Omeros Corporation: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.